192 related articles for article (PubMed ID: 15870832)
1. Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer.
Songun I; Litvinov SV; van de Velde CJ; Pals ST; Hermans J; van Krieken JH
Br J Cancer; 2005 May; 92(9):1767-72. PubMed ID: 15870832
[TBL] [Abstract][Full Text] [Related]
2. Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance.
Fong D; Steurer M; Obrist P; Barbieri V; Margreiter R; Amberger A; Laimer K; Gastl G; Tzankov A; Spizzo G
J Clin Pathol; 2008 Jan; 61(1):31-5. PubMed ID: 16775119
[TBL] [Abstract][Full Text] [Related]
3. Expression of Ep-CAM in intestinal metaplasia, gastric epithelial dysplasia and gastric adenocarcinoma.
Joo M; Kim H; Kim MK; Yu HJ; Kim JP
J Gastroenterol Hepatol; 2005 Jul; 20(7):1039-45. PubMed ID: 15955212
[TBL] [Abstract][Full Text] [Related]
4. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
Went P; Vasei M; Bubendorf L; Terracciano L; Tornillo L; Riede U; Kononen J; Simon R; Sauter G; Baeuerle PA
Br J Cancer; 2006 Jan; 94(1):128-35. PubMed ID: 16404366
[TBL] [Abstract][Full Text] [Related]
5. Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Dutch Gastric Cancer Group (DGCG).
Songun I; van de Velde CJ; Hermans J; Pals ST; Verspaget HW; Vis AN; Menon AG; Litvinov SV; van Krieken JH
Br J Cancer; 1996 Dec; 74(11):1783-8. PubMed ID: 8956793
[TBL] [Abstract][Full Text] [Related]
6. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.
Piyathilake CJ; Frost AR; Weiss H; Manne U; Heimburger DC; Grizzle WE
Hum Pathol; 2000 Apr; 31(4):482-7. PubMed ID: 10821496
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Ep-CAM AND Her-2/neu overexpression in invasive breast cancer.
Spizzo G; Obrist P; Ensinger C; Theurl I; Dünser M; Ramoni A; Gunsilius E; Eibl G; Mikuz G; Gastl G
Int J Cancer; 2002 Apr; 98(6):883-8. PubMed ID: 11948467
[TBL] [Abstract][Full Text] [Related]
8. Loss of membranous Ep-CAM in budding colorectal carcinoma cells.
Gosens MJ; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
Mod Pathol; 2007 Feb; 20(2):221-32. PubMed ID: 17361206
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma.
Deveci MS; Deveci G
Gastric Cancer; 2007; 10(2):112-6. PubMed ID: 17577621
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer.
Spizzo G; Went P; Dirnhofer S; Obrist P; Moch H; Baeuerle PA; Mueller-Holzner E; Marth C; Gastl G; Zeimet AG
Gynecol Oncol; 2006 Nov; 103(2):483-8. PubMed ID: 16678891
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.
Thurmond LM; Stimmel JB; Ingram AC; Ryan CH; Murray DM; Eberwein DJ; Witherspoon SM; Knick VC
Cancer Immunol Immunother; 2003 Jul; 52(7):429-37. PubMed ID: 12695858
[TBL] [Abstract][Full Text] [Related]
13. [Expressions of Ep-CAM and cyclin D1 and their clinical significance in gallbladder carcinoma].
Ren G; Yu G; Liu LW; Ma L
Zhonghua Zhong Liu Za Zhi; 2009 Nov; 31(11):841-4. PubMed ID: 20137349
[TBL] [Abstract][Full Text] [Related]
14. Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker.
Stoecklein NH; Siegmund A; Scheunemann P; Luebke AM; Erbersdobler A; Verde PE; Eisenberger CF; Peiper M; Rehders A; Esch JS; Knoefel WT; Hosch SB
BMC Cancer; 2006 Jun; 6():165. PubMed ID: 16796747
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion molecule-specific immunotherapy.
Bellone S; Siegel ER; Cocco E; Cargnelutti M; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Int J Gynecol Cancer; 2009 Jul; 19(5):860-6. PubMed ID: 19574774
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of E-cadherin and Ep-CAM in cervical lymph node metastasis of supraglottic larynx carcinoma.
Ali Bayram ; Yüce İ; Çağlı S; Canöz Ö; Güney E
Am J Otolaryngol; 2015; 36(6):736-40. PubMed ID: 26545462
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic value and functional roles of CD44v6 in gastric cancer.
Xie JW; Chen PC; Zheng CH; Li P; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Lin Y; Huang CM
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1809-17. PubMed ID: 25809905
[TBL] [Abstract][Full Text] [Related]
19. Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.
Schmidt M; Hasenclever D; Schaeffer M; Boehm D; Cotarelo C; Steiner E; Lebrecht A; Siggelkow W; Weikel W; Schiffer-Petry I; Gebhard S; Pilch H; Gehrmann M; Lehr HA; Koelbl H; Hengstler JG; Schuler M
Clin Cancer Res; 2008 Sep; 14(18):5849-55. PubMed ID: 18794096
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17-1A and BerEP4.
Brezicka T
Acta Oncol; 2005; 44(7):723-7. PubMed ID: 16227163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
